円形脱毛症の治療薬PF-06651600

基本情報

NCT ID

NCT03732807

ステータス

完了

試験のフェーズ

第2/第3相

試験タイプ

介入

目標被験者数

718

治験依頼者名

Pfizer

概要

This is a global Phase 2b/3 study to evaluate the safety and effectiveness of an investigational study drug (called PF-06651600) in adults and adolescents (12 years and older) who have 50% or greater scalp hair loss. The study is placebo-controlled, meaning that some patients entering the study will not receive active study drug but will receive tablets with no active ingredients (a placebo). This is a dose-ranging study, investigating 5 different dosing regimens. It will be double-blinded, meaning that the sponsor, the study doctors, the staff, and the patients will not know whether a patient is on active study drug (or the dose) or placebo.

対象疾患

介入

依頼者（Sponsor）

実施施設 (6)